- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Events & Workshops
High-throughput MALDI TOF mass spectrometry for drug discovery
ABOUT THIS WEBINAR
With its flexibility, the ability to analyse physiological enzyme products and the recent advances in speed, MALDI TOF mass spectrometry has become a real alternative for high-throughput drug screening. In this webinar, we will present sensitive MALDI TOF MS-based high throughput DUB and E2/E3 in vitro assays as deregulation of these enzymes is correlated with a variety of human diseases, particularly neurodegenerative disease and cancer, making them key drug targets. These novel assays will dramatically improve our ability to identify compounds that specifically target these enzymes.
Dr Matthias Trost, Programme Leader & Head of Proteomics for the MRC Protein Phosphorylation and Ubiquitylation Unit at University of Dundee, will present his recent work using MALDI TOF mass spectrometry in the ubiquitin system. He will further discuss the newest technological advances such as the Rapiflex MALDI TOF mass spectrometer which has sped up acquisition 5-10x compared to previous models making it the ideal instrument for high-throughput screening.
Matthias studied chemistry at the Albert-Ludwigs University in Freiburg, Germany and at the University of Manchester, UK. He received a Ph.D. in 2004 while working at the Helmholtz Centre for Infection Research, Braunschweig, Germany, followed by postdoctoral research at the University of Montreal. Since 2010 Matthias is a programme leader at MRC Protein Phosphorylation and Ubiquitylation Unit at the University of Dundee. His research is using proteomics tools to understand signalling events in innate immunity. His lab is also actively developing MALDI TOF methods for high-throughput screening and chromatography for deep-proteome and phosphoproteome analysis.
This webinar took place live on Tuesday 24 May – click here to watch the recording.
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd B&W Tek Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) EUROGENTEC F.P.S. Food and Pharma Systems Srl IDBS JEOL Europe L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited Metrohm Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Panasonic Biomedical Sales Europe B.V. PerkinElmer Inc ReAgent Russell Finex Limited Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Watson-Marlow Fluid Technology Group Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Yusen Logistics